Home > Insider Trading > Filing (0001214659-22-005391)

Filing Details

Accession Number:: 0001214659-22-005391
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-04-18 16:12:34
Reporting Period:: 2022-04-14

Accepted Time:: 2022-04-18 16:12:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581280	Twist Bioscience Corp	TWST	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1252038	M James Thorburn	C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-04-14	3,503	$11.59	50,191	No	4	M	Direct
Common Stock	Acquisiton	2022-04-14	1,600	$23.33	51,791	No	4	M	Direct
Common Stock	Acquisiton	2022-04-14	1,517	$26.66	53,308	No	4	M	Direct
Common Stock	Disposition	2022-04-14	5,493	$42.71	47,815	No	4	S	Direct
Common Stock	Disposition	2022-04-14	1,127	$43.52	46,688	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2022-04-14	3,503	$0.00	3,503	$11.59
Common Stock	Employee Stock Option (right to buy)	Disposition	2022-04-14	1,600	$0.00	1,600	$23.33
Common Stock	Employee Stock Option (right to buy)	Disposition	2022-04-14	1,517	$0.00	1,517	$26.66

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,827	2028-06-06	No	4	M	Direct
24,148	2029-10-23	No	4	M	Direct
38,864	2028-11-18	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
Represents the weighted average sales price per share. The shares sold at prices ranging from $42.23 to $43.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $43.24 to $44.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
25% of the shares subject to the option vested and became exercisable on April 23, 2019, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.